6uyf: Difference between revisions

From Proteopedia
Jump to navigationJump to search
OCA (talk | contribs)
No edit summary
OCA (talk | contribs)
No edit summary
Line 3: Line 3:
<StructureSection load='6uyf' size='340' side='right'caption='[[6uyf]], [[Resolution|resolution]] 2.06&Aring;' scene=''>
<StructureSection load='6uyf' size='340' side='right'caption='[[6uyf]], [[Resolution|resolution]] 2.06&Aring;' scene=''>
== Structural highlights ==
== Structural highlights ==
<table><tr><td colspan='2'>[[6uyf]] is a 3 chain structure with sequence from [http://en.wikipedia.org/wiki/Human Human] and [http://en.wikipedia.org/wiki/Recombinant_hepatitis_c_virus_hk6a/jfh-1 Recombinant hepatitis c virus hk6a/jfh-1]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=6UYF OCA]. For a <b>guided tour on the structure components</b> use [http://proteopedia.org/fgij/fg.htm?mol=6UYF FirstGlance]. <br>
<table><tr><td colspan='2'>[[6uyf]] is a 3 chain structure with sequence from [https://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens] and [https://en.wikipedia.org/wiki/Recombinant_Hepatitis_C_virus_HK6a/JFH-1 Recombinant Hepatitis C virus HK6a/JFH-1]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=6UYF OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=6UYF FirstGlance]. <br>
</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=BMA:BETA-D-MANNOSE'>BMA</scene>, <scene name='pdbligand=MAN:ALPHA-D-MANNOSE'>MAN</scene>, <scene name='pdbligand=NAG:N-ACETYL-D-GLUCOSAMINE'>NAG</scene></td></tr>
</td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 2.06&#8491;</td></tr>
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://proteopedia.org/fgij/fg.htm?mol=6uyf FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=6uyf OCA], [http://pdbe.org/6uyf PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=6uyf RCSB], [http://www.ebi.ac.uk/pdbsum/6uyf PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=6uyf ProSAT]</span></td></tr>
<tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=BMA:BETA-D-MANNOSE'>BMA</scene>, <scene name='pdbligand=MAN:ALPHA-D-MANNOSE'>MAN</scene>, <scene name='pdbligand=NAG:N-ACETYL-D-GLUCOSAMINE'>NAG</scene></td></tr>
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=6uyf FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=6uyf OCA], [https://pdbe.org/6uyf PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=6uyf RCSB], [https://www.ebi.ac.uk/pdbsum/6uyf PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=6uyf ProSAT]</span></td></tr>
</table>
</table>
== Function ==
[https://www.uniprot.org/uniprot/B9V0E2_9HEPC B9V0E2_9HEPC]
<div style="background-color:#fffaf0;">
<div style="background-color:#fffaf0;">
== Publication Abstract from PubMed ==
== Publication Abstract from PubMed ==
Line 16: Line 19:
</div>
</div>
<div class="pdbe-citations 6uyf" style="background-color:#fffaf0;"></div>
<div class="pdbe-citations 6uyf" style="background-color:#fffaf0;"></div>
==See Also==
*[[Antibody 3D structures|Antibody 3D structures]]
== References ==
== References ==
<references/>
<references/>
__TOC__
__TOC__
</StructureSection>
</StructureSection>
[[Category: Human]]
[[Category: Homo sapiens]]
[[Category: Large Structures]]
[[Category: Large Structures]]
[[Category: Recombinant hepatitis c virus hk6a/jfh-1]]
[[Category: Recombinant Hepatitis C virus HK6a/JFH-1]]
[[Category: Tzarum, N]]
[[Category: Tzarum N]]
[[Category: Wilson, I A]]
[[Category: Wilson IA]]
[[Category: Zhu, J]]
[[Category: Zhu J]]
[[Category: Bnab]]
[[Category: Broadly neutralizing antibody]]
[[Category: E2 core]]
[[Category: Hcv]]
[[Category: Self-assembly nanoparticle]]
[[Category: Vaccine design]]
[[Category: Viral proein-immune system complex]]
[[Category: Viral protein-immune system complex]]